...Good morning. This is David Amsellem from the Piper Sandler specialty pharma team, day three of the Piper Sandler Healthcare Conference, or I should say 34th Annual Piper Sandler Healthcare Conference. And we're delighted to have Cara Therapeutics with us, Chris Posner, CEO; Joana Goncalves, Chief Medical Officer, did I get your title, right? I do, okay. And Ryan Maynard, CFO. So thanks everyone for joining us. So lots to talk about given the commercialization of KORSUVA. So I thought we would just dive right in, if that's okay. Chris Posner ...